{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:55:54Z","timestamp":1790596554042,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.transci.2026.104516","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:24:56Z","timestamp":1786429496000},"page":"104516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expert insights into AI-assisted platelet bioproducts for patient-centered care in selected clinical scenarios and regenerative applications: From conventional concentrates to regenerative medicine"],"prefix":"10.1016","volume":"65","author":[{"given":"Irena","family":"Sniecinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerard","family":"Seghatchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104516_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","article-title":"Applications of the regenerative capacity of platelets in modern medicine","volume":"64","author":"Cecerska-Heryc","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"issue":"20","key":"10.1016\/j.transci.2026.104516_bib2","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.3390\/ijms21207794","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.transci.2026.104516_bib3","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bbapap.2012.10.015","article-title":"Platelet-derived growth factors and their receptors: structural and functional perspectives","volume":"1834","author":"Chen","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11033-024-09890-y","article-title":"Leukocyte- and platelet-rich fibrin for enhanced tissue repair: an in vitro study characterizing cellular composition, growth factor kinetics and transcriptomic insights","volume":"51","author":"Coucke","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"2","key":"10.1016\/j.transci.2026.104516_bib5","article-title":"Platelet-derived microparticles and their cargos: the past, present and future","volume":"19","author":"Guo","year":"2024","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"10.1016\/j.transci.2026.104516_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13312","article-title":"Human platelet lysate-derived extracellular vesicles enhance angiogenesis through miR-126","volume":"55","author":"Bordin","year":"2022","journal-title":"Cell Prolif"},{"issue":"2","key":"10.1016\/j.transci.2026.104516_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jocd.16709","article-title":"Therapeutic potential of extracellular vesicles (exosomes) derived from platelet-rich plasma: a literature review","volume":"24","author":"Gupta","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.transci.2026.104516_bib8","article-title":"The evolution of three generations of platelet concentrates products: a leap from classical formulations to the era of extracellular vesicles","volume":"13","author":"Li","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.transci.2026.104516_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fmed.2018.00239","article-title":"On the way to in vitro platelet production","volume":"5","author":"Strassel","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"22","key":"10.1016\/j.transci.2026.104516_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood.2024024601","article-title":"Platelet generation in vivo and in vitro","volume":"144","author":"Furniss","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2026.104516_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s44313-025-00071-9","article-title":"Cell-based artificial platelet production: historical milestones, emerging trends, and future directions","volume":"60","author":"Kim","year":"2025","journal-title":"Blood Res"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13619-023-00175-6","article-title":"Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges","volume":"12","author":"Zheng","year":"2023","journal-title":"Cell Regen"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s13287-024-03966-z","article-title":"iPSC-derived megakaryocytes and platelets accelerate wound healing and angiogenesis","volume":"15","author":"Kosaka","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.transci.2026.104516_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3364","article-title":"Current status of platelet manufacturing in 3D or bioreactors","volume":"39","author":"Kweon","year":"2023","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.transci.2026.104516_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.reth.2025.07.001","article-title":"Culturing potential: advances in ex vivo cell culture systems for hematopoietic cell-based regenerative therapies","volume":"30","author":"Sugiyama-Finnis","year":"2025","journal-title":"Regen Ther"},{"issue":"5","key":"10.1016\/j.transci.2026.104516_bib16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.18063\/ijb.750","article-title":"Enzymatic post-crosslinking of printed hydrogels of methacrylated gelatin and tyramine-conjugated 8-arm poly(ethylene glycol) to prepare interpenetrating 3D network structures","volume":"9","author":"Liang","year":"2023","journal-title":"Int J Bioprint"},{"key":"10.1016\/j.transci.2026.104516_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117131","article-title":"Emerging platelet-based drug delivery systems","volume":"177","author":"Fang","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12951-019-0494-y","article-title":"Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery","volume":"17","author":"Wang","year":"2019","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.transci.2026.104516_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"issue":"45","key":"10.1016\/j.transci.2026.104516_bib20","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1039\/C8TB02301H","article-title":"Platelets and their biomimetics for regenerative medicine and cancer therapies","volume":"6","author":"Li","year":"2018","journal-title":"J Mater Chem B"},{"issue":"9","key":"10.1016\/j.transci.2026.104516_bib21","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1039\/D4BM00029C","article-title":"Engineering unactivated platelets for targeted drug delivery","volume":"12","author":"Wu","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.transci.2026.104516_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122478","article-title":"Platelet-derived drug delivery systems: pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond","volume":"306","author":"Zhu","year":"2024","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.transci.2026.104516_bib23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood.2024024405","article-title":"Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices","volume":"144","author":"Strong","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2026.104516_bib24","first-page":"117","article-title":"vitro evidence supporting applications of platelet derivatives in regenerative medicine","volume":"18","author":"Giusti","year":"2020","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.transci.2026.104516_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/acsbiomaterials.7b00013","article-title":"Platelets and platelet-inspired biomaterials technologies in wound healing applications","volume":"4","author":"Sekhon","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"issue":"6","key":"10.1016\/j.transci.2026.104516_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s13770-023-00560-x","article-title":"Biotherapeutic applications of platelet-rich plasma in regenerative medicine","volume":"20","author":"Pineda-Cortel","year":"2023","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1186\/s40001-025-03253-4","article-title":"Efficacy and safety of platelet-rich plasma injections for the treatment of knee osteoarthrosis: a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Wang","year":"2025","journal-title":"Eur J Med Res"},{"issue":"8","key":"10.1016\/j.transci.2026.104516_bib28","article-title":"Third-generation platelet concentrates in periodontal regeneration: gaining ground in the field of regeneration","volume":"14","author":"Shirbhate","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/ijms25010482","article-title":"Biological and cellular properties of advanced platelet-rich fibrin (A-PRF) compared to other platelet concentrates: systematic review and meta-analysis","volume":"25","author":"Pereira","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib30","article-title":"Next-generation platelet concentrate: Alb-PRF outperformed PRP and H-PRF in promoting endothelial function and wound healing","volume":"16","author":"Shen","year":"2026","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.transci.2026.104516_bib31","doi-asserted-by":"crossref","first-page":"13472","DOI":"10.1039\/D2RA00985D","article-title":"Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration","volume":"12","author":"Karimi","year":"2022","journal-title":"RSC Adv"},{"issue":"3","key":"10.1016\/j.transci.2026.104516_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00784-017-2211-2","article-title":"Effectiveness and predictability of titanium-prepared platelet-rich fibrin for the management of multiple gingival recessions","volume":"22","author":"Uzun","year":"2018","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.transci.2026.104516_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cryobiol.2025.105214","article-title":"Long-term stability of preservative-free and lyophilized PRGF eye drops stored at different temperature conditions: in vitro comparative study","volume":"119","author":"Anitua","year":"2025","journal-title":"Cryobiology"},{"issue":"7","key":"10.1016\/j.transci.2026.104516_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12332","article-title":"First-in-human clinical trial of allogeneic platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing","volume":"12","author":"Johnson","year":"2023","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"10.1016\/j.transci.2026.104516_bib35","article-title":"Fusing biomimetic engineering with nanotechnology: the rise of platelet membrane-coated nanoparticles as a versatile platform for biomedical innovation","volume":"8","author":"Syed Altaf","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.transci.2026.104516_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2024.07.013","article-title":"From bench to bedside: platelet biomimetic nanoparticles as a promising carrier for personalized drug delivery","volume":"373","author":"Safdar","year":"2024","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.transci.2026.104516_bib37","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3390\/ijms24054334","article-title":"TR. Neuroprotective strategies for ischemic stroke-future perspectives","volume":"24","author":"Haupt","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.transci.2026.104516_bib38","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1021\/acsnano.3c04423","article-title":"Targeted delivery of RGD-CD146+CD271+ human umbilical cord mesenchymal stem cell-derived exosomes promotes blood-spinal cord barrier repair after spinal cord injury","volume":"17","author":"Xie","year":"2023","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.transci.2026.104516_bib39","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s12033-023-00932-7","article-title":"Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing","volume":"66","author":"Aslan","year":"2024","journal-title":"Mol Biotechnol"},{"issue":"6","key":"10.1016\/j.transci.2026.104516_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400551","article-title":"Empowering exosomes with aptamers for precision theranostics","volume":"9","author":"Zheng","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.transci.2026.104516_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.598816","article-title":"Technical procedures for preparation and administration of platelet-rich plasma and related products: a scoping review","volume":"8","author":"Pachito","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.transci.2026.104516_bib42","first-page":"1171","article-title":"First- vs. second-generation autologous platelet concentrates and their implications for wound healing: differences in proteome and secretome","volume":"11","author":"Stiller","year":"2024","journal-title":"Bioeng (Basel)"},{"issue":"15","key":"10.1016\/j.transci.2026.104516_bib43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/cells14151206","article-title":"Not all platelets are created equal: a review on platelet aging and functional quality in regenerative medicine","volume":"14","author":"Costa","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.transci.2026.104516_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.reth.2020.09.004","article-title":"Proteomic analysis of platelet-rich and platelet-poor plasma","volume":"15","author":"Miroshnychenko","year":"2020","journal-title":"Regen Ther"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib45","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41598-020-57754-9","article-title":"Functional properties of human platelets derived in vitro from CD34+ cells","volume":"10","author":"Do Sacramento","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.transci.2026.104516_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102675","article-title":"Platelet-rich plasma in treatment of musculoskeletal pathologies","volume":"58","author":"Mehrabani","year":"2019","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2026.104516_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102716","article-title":"Platelet-derived bioproducts: classification update, applications, concerns and new perspectives","volume":"59","author":"Acebes-Huerta","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"12","key":"10.1016\/j.transci.2026.104516_bib48","first-page":"671","article-title":"On the quest for in vitro platelet production by re-tailoring the concepts of megakaryocyte differentiation","volume":"56","author":"Martinez-Botia","year":"2020","journal-title":"Med (Kaunas)"},{"issue":"6","key":"10.1016\/j.transci.2026.104516_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.104014","article-title":"Guest editorial: advancements in blood donor factors: understanding their variability and implications on the clinical outcomes of recipients. Where are we now!","volume":"63","author":"Seghatchian","year":"2024","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:04:17Z","timestamp":1790593457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1473050226001485"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104516","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert insights into AI-assisted platelet bioproducts for patient-centered care in selected clinical scenarios and regenerative applications: From conventional concentrates to regenerative medicine","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104516"}}